nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—Conjunctival oedema—Carmustine—malignant glioma	0.04	0.0934	CcSEcCtD
Bimatoprost—Retinal haemorrhage—Carmustine—malignant glioma	0.0341	0.0795	CcSEcCtD
Bimatoprost—Skin hyperpigmentation—Carmustine—malignant glioma	0.0187	0.0436	CcSEcCtD
Bimatoprost—Burning sensation—Carmustine—malignant glioma	0.016	0.0373	CcSEcCtD
Bimatoprost—Scotoma—Carmustine—malignant glioma	0.0146	0.0341	CcSEcCtD
Bimatoprost—Scotoma—Temozolomide—malignant glioma	0.0141	0.033	CcSEcCtD
Bimatoprost—Dry eye—Temozolomide—malignant glioma	0.00991	0.0231	CcSEcCtD
Bimatoprost—Eye pain—Carmustine—malignant glioma	0.00892	0.0208	CcSEcCtD
Bimatoprost—Eye pain—Temozolomide—malignant glioma	0.00862	0.0201	CcSEcCtD
Bimatoprost—Diplopia—Carmustine—malignant glioma	0.00806	0.0188	CcSEcCtD
Bimatoprost—Diplopia—Temozolomide—malignant glioma	0.00779	0.0182	CcSEcCtD
Bimatoprost—Liver function test abnormal—Carmustine—malignant glioma	0.00744	0.0174	CcSEcCtD
Bimatoprost—Dry skin—Temozolomide—malignant glioma	0.00714	0.0167	CcSEcCtD
Bimatoprost—Bronchitis—Temozolomide—malignant glioma	0.00647	0.0151	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00625	0.0146	CcSEcCtD
Bimatoprost—Depression—Carmustine—malignant glioma	0.00619	0.0145	CcSEcCtD
Bimatoprost—Depression—Temozolomide—malignant glioma	0.00598	0.014	CcSEcCtD
Bimatoprost—Sinusitis—Temozolomide—malignant glioma	0.00563	0.0131	CcSEcCtD
Bimatoprost—Oedema peripheral—Carmustine—malignant glioma	0.00549	0.0128	CcSEcCtD
Bimatoprost—Connective tissue disorder—Carmustine—malignant glioma	0.00548	0.0128	CcSEcCtD
Bimatoprost—Visual impairment—Carmustine—malignant glioma	0.00537	0.0125	CcSEcCtD
Bimatoprost—Pharyngitis—Temozolomide—malignant glioma	0.00535	0.0125	CcSEcCtD
Bimatoprost—Oedema peripheral—Temozolomide—malignant glioma	0.00531	0.0124	CcSEcCtD
Bimatoprost—Connective tissue disorder—Temozolomide—malignant glioma	0.00529	0.0124	CcSEcCtD
Bimatoprost—Eye disorder—Carmustine—malignant glioma	0.00521	0.0122	CcSEcCtD
Bimatoprost—Visual impairment—Temozolomide—malignant glioma	0.00519	0.0121	CcSEcCtD
Bimatoprost—Eye disorder—Temozolomide—malignant glioma	0.00503	0.0118	CcSEcCtD
Bimatoprost—Angiopathy—Temozolomide—malignant glioma	0.00489	0.0114	CcSEcCtD
Bimatoprost—Mediastinal disorder—Temozolomide—malignant glioma	0.00485	0.0113	CcSEcCtD
Bimatoprost—Erythema—Carmustine—malignant glioma	0.00485	0.0113	CcSEcCtD
Bimatoprost—Erythema—Temozolomide—malignant glioma	0.00469	0.011	CcSEcCtD
Bimatoprost—Vision blurred—Carmustine—malignant glioma	0.00457	0.0107	CcSEcCtD
Bimatoprost—Vision blurred—Temozolomide—malignant glioma	0.00442	0.0103	CcSEcCtD
Bimatoprost—Vertigo—Temozolomide—malignant glioma	0.00421	0.00984	CcSEcCtD
Bimatoprost—Hypertension—Carmustine—malignant glioma	0.00419	0.00978	CcSEcCtD
Bimatoprost—Palpitations—Temozolomide—malignant glioma	0.00414	0.00968	CcSEcCtD
Bimatoprost—Chest pain—Carmustine—malignant glioma	0.00413	0.00965	CcSEcCtD
Bimatoprost—Anxiety—Carmustine—malignant glioma	0.00412	0.00961	CcSEcCtD
Bimatoprost—Cough—Temozolomide—malignant glioma	0.00409	0.00956	CcSEcCtD
Bimatoprost—Hypertension—Temozolomide—malignant glioma	0.00405	0.00945	CcSEcCtD
Bimatoprost—Anxiety—Temozolomide—malignant glioma	0.00398	0.00929	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00396	0.00926	CcSEcCtD
Bimatoprost—Infection—Carmustine—malignant glioma	0.00393	0.00919	CcSEcCtD
Bimatoprost—Dry mouth—Temozolomide—malignant glioma	0.0039	0.00912	CcSEcCtD
Bimatoprost—Infection—Temozolomide—malignant glioma	0.0038	0.00888	CcSEcCtD
Bimatoprost—Nervous system disorder—Temozolomide—malignant glioma	0.00375	0.00876	CcSEcCtD
Bimatoprost—Skin disorder—Temozolomide—malignant glioma	0.00372	0.00868	CcSEcCtD
Bimatoprost—Insomnia—Carmustine—malignant glioma	0.00358	0.00836	CcSEcCtD
Bimatoprost—Dyspnoea—Carmustine—malignant glioma	0.00353	0.00824	CcSEcCtD
Bimatoprost—Somnolence—Carmustine—malignant glioma	0.00352	0.00822	CcSEcCtD
Bimatoprost—Insomnia—Temozolomide—malignant glioma	0.00346	0.00808	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Carmustine—malignant glioma	0.00342	0.00798	CcSEcCtD
Bimatoprost—Dyspnoea—Temozolomide—malignant glioma	0.00341	0.00797	CcSEcCtD
Bimatoprost—Somnolence—Temozolomide—malignant glioma	0.0034	0.00794	CcSEcCtD
Bimatoprost—Pain—Carmustine—malignant glioma	0.00339	0.00791	CcSEcCtD
Bimatoprost—Dyspepsia—Temozolomide—malignant glioma	0.00337	0.00787	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Temozolomide—malignant glioma	0.0033	0.00772	CcSEcCtD
Bimatoprost—Pain—Temozolomide—malignant glioma	0.00327	0.00764	CcSEcCtD
Bimatoprost—Asthenia—Carmustine—malignant glioma	0.00284	0.00663	CcSEcCtD
Bimatoprost—Asthenia—Temozolomide—malignant glioma	0.00275	0.00641	CcSEcCtD
Bimatoprost—Pruritus—Temozolomide—malignant glioma	0.00271	0.00632	CcSEcCtD
Bimatoprost—Dizziness—Carmustine—malignant glioma	0.00262	0.00612	CcSEcCtD
Bimatoprost—Dizziness—Temozolomide—malignant glioma	0.00253	0.00591	CcSEcCtD
Bimatoprost—Rash—Carmustine—malignant glioma	0.0025	0.00583	CcSEcCtD
Bimatoprost—Dermatitis—Carmustine—malignant glioma	0.00249	0.00583	CcSEcCtD
Bimatoprost—Headache—Carmustine—malignant glioma	0.00248	0.00579	CcSEcCtD
Bimatoprost—Rash—Temozolomide—malignant glioma	0.00241	0.00563	CcSEcCtD
Bimatoprost—Dermatitis—Temozolomide—malignant glioma	0.00241	0.00563	CcSEcCtD
Bimatoprost—Headache—Temozolomide—malignant glioma	0.0024	0.0056	CcSEcCtD
Bimatoprost—Nausea—Carmustine—malignant glioma	0.00235	0.00549	CcSEcCtD
Bimatoprost—Nausea—Temozolomide—malignant glioma	0.00227	0.00531	CcSEcCtD
Bimatoprost—Tafluprost—PTGS2—malignant glioma	0.00138	1	CrCbGaD
Bimatoprost—PTGFR—Signaling Pathways—KNG1—malignant glioma	0.00048	0.000842	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CAT—malignant glioma	0.000478	0.000839	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000477	0.000835	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TERT—malignant glioma	0.000476	0.000834	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—HLA-A—malignant glioma	0.000476	0.000834	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL2—malignant glioma	0.000473	0.00083	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TERT—malignant glioma	0.000472	0.000827	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KNG1—malignant glioma	0.00047	0.000824	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PDGFB—malignant glioma	0.000464	0.000814	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NOTCH2—malignant glioma	0.000463	0.000813	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—FGFR1—malignant glioma	0.000462	0.000809	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PDGFB—malignant glioma	0.00046	0.000807	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—AKT2—malignant glioma	0.00046	0.000807	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—FGFR1—malignant glioma	0.000458	0.000803	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NTRK1—malignant glioma	0.000458	0.000802	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—HIF1A—malignant glioma	0.000455	0.000797	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KNG1—malignant glioma	0.000454	0.000795	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—NCOR1—malignant glioma	0.000452	0.000792	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—HIF1A—malignant glioma	0.000451	0.000791	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—AKT2—malignant glioma	0.00045	0.00079	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NTRK1—malignant glioma	0.000448	0.000785	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PIK3CD—malignant glioma	0.000442	0.000775	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CAV1—malignant glioma	0.00044	0.000771	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CAV1—malignant glioma	0.000436	0.000765	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PIK3CD—malignant glioma	0.000433	0.000759	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NTRK1—malignant glioma	0.000432	0.000758	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—KDR—malignant glioma	0.000431	0.000756	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MMP3—malignant glioma	0.000426	0.000746	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—PIK3CB—malignant glioma	0.000424	0.000744	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CDKN2B—malignant glioma	0.000422	0.000739	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MMP3—malignant glioma	0.000417	0.00073	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PIK3CB—malignant glioma	0.000415	0.000728	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—F2—malignant glioma	0.000415	0.000728	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—FN1—malignant glioma	0.000415	0.000728	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—BAD—malignant glioma	0.000414	0.000725	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CDKN2B—malignant glioma	0.000413	0.000724	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—BAD—malignant glioma	0.00041	0.000719	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NOTCH1—malignant glioma	0.00041	0.000718	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PTK2—malignant glioma	0.00041	0.000718	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CXCL8—malignant glioma	0.000408	0.000715	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NOTCH1—malignant glioma	0.000406	0.000712	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HES1—malignant glioma	0.000402	0.000705	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MMP3—malignant glioma	0.000402	0.000704	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CD80—malignant glioma	0.000401	0.000704	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PTK2—malignant glioma	0.000401	0.000703	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—APC—malignant glioma	0.000401	0.000702	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NCOR1—malignant glioma	0.0004	0.000701	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CXCL8—malignant glioma	0.000399	0.0007	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CDKN2B—malignant glioma	0.000398	0.000698	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CD80—malignant glioma	0.000398	0.000698	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CG—malignant glioma	0.000397	0.000696	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—APC—malignant glioma	0.000397	0.000696	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—EGF—malignant glioma	0.000396	0.000694	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—RAF1—malignant glioma	0.000395	0.000692	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HES1—malignant glioma	0.000394	0.000691	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTPN11—malignant glioma	0.000394	0.00069	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EGF—malignant glioma	0.000393	0.000688	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NCOR1—malignant glioma	0.000392	0.000687	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PTPN11—malignant glioma	0.00039	0.000684	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—IL2—malignant glioma	0.00039	0.000683	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTK2—malignant glioma	0.000387	0.000678	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—RAF1—malignant glioma	0.000386	0.000677	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PIK3CB—malignant glioma	0.000385	0.000676	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PDGFRA—malignant glioma	0.000383	0.000672	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—IL2—malignant glioma	0.000381	0.000669	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HES1—malignant glioma	0.00038	0.000666	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NCOR1—malignant glioma	0.000378	0.000662	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PIK3CB—malignant glioma	0.000377	0.000661	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—BRAF—malignant glioma	0.000377	0.00066	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PDGFRA—malignant glioma	0.000375	0.000657	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—BRAF—malignant glioma	0.000373	0.000655	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SPP1—malignant glioma	0.000372	0.000652	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CXCL8—malignant glioma	0.00037	0.000649	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CAV1—malignant glioma	0.000368	0.000646	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—AKT2—malignant glioma	0.000367	0.000643	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SPP1—malignant glioma	0.000364	0.000638	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AKT2—malignant glioma	0.000364	0.000637	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CXCL8—malignant glioma	0.000362	0.000635	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—EGFR—malignant glioma	0.000362	0.000635	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PDGFRA—malignant glioma	0.000362	0.000634	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL2—malignant glioma	0.000354	0.00062	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TERT—malignant glioma	0.000353	0.000618	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CD—malignant glioma	0.000352	0.000617	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000352	0.000617	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SPP1—malignant glioma	0.000351	0.000616	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CD—malignant glioma	0.000349	0.000612	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL2—malignant glioma	0.000346	0.000607	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—PIK3CA—malignant glioma	0.000346	0.000606	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TERT—malignant glioma	0.000345	0.000605	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PDGFB—malignant glioma	0.000344	0.000603	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—FGFR1—malignant glioma	0.000342	0.0006	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—KRAS—malignant glioma	0.000342	0.000599	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—FGF2—malignant glioma	0.000337	0.000591	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HIF1A—malignant glioma	0.000337	0.000591	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PDGFB—malignant glioma	0.000337	0.000591	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CG—malignant glioma	0.000336	0.000588	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FGFR1—malignant glioma	0.000335	0.000588	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—FGF2—malignant glioma	0.000334	0.000586	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TERT—malignant glioma	0.000333	0.000584	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HIF1A—malignant glioma	0.00033	0.000579	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CAV1—malignant glioma	0.000326	0.000572	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PDGFB—malignant glioma	0.000325	0.00057	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PPARG—malignant glioma	0.000324	0.000568	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FGFR1—malignant glioma	0.000323	0.000567	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KDR—malignant glioma	0.000322	0.000565	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CAV1—malignant glioma	0.000319	0.00056	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HIF1A—malignant glioma	0.000318	0.000558	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KDR—malignant glioma	0.000316	0.000553	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MDM2—malignant glioma	0.000316	0.000553	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—RAF1—malignant glioma	0.000314	0.000551	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—PIK3CA—malignant glioma	0.000314	0.000551	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MDM2—malignant glioma	0.000313	0.000549	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RAF1—malignant glioma	0.000312	0.000547	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—ERBB2—malignant glioma	0.000311	0.000545	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—F2—malignant glioma	0.00031	0.000544	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—FN1—malignant glioma	0.00031	0.000544	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ERBB2—malignant glioma	0.000308	0.000541	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CAV1—malignant glioma	0.000308	0.00054	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CB—malignant glioma	0.000307	0.000538	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—BAD—malignant glioma	0.000307	0.000538	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KDR—malignant glioma	0.000305	0.000534	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CB—malignant glioma	0.000304	0.000534	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTGS2—malignant glioma	0.000304	0.000533	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—F2—malignant glioma	0.000304	0.000533	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FN1—malignant glioma	0.000304	0.000533	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NOTCH1—malignant glioma	0.000304	0.000533	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—BAD—malignant glioma	0.0003	0.000526	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CD80—malignant glioma	0.000298	0.000522	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NOTCH1—malignant glioma	0.000297	0.000521	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CG—malignant glioma	0.000297	0.000521	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—APC—malignant glioma	0.000297	0.000521	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CD—malignant glioma	0.000295	0.000517	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EGF—malignant glioma	0.000294	0.000515	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FN1—malignant glioma	0.000293	0.000514	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—F2—malignant glioma	0.000293	0.000514	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CXCL8—malignant glioma	0.000293	0.000513	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PTPN11—malignant glioma	0.000292	0.000512	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CD80—malignant glioma	0.000291	0.000511	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—APC—malignant glioma	0.000291	0.00051	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CG—malignant glioma	0.000291	0.00051	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—BAD—malignant glioma	0.00029	0.000508	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EGF—malignant glioma	0.000287	0.000504	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NOTCH1—malignant glioma	0.000287	0.000503	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PTPN11—malignant glioma	0.000286	0.000501	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—AKT1—malignant glioma	0.000283	0.000495	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CD80—malignant glioma	0.000281	0.000493	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CG—malignant glioma	0.000281	0.000492	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—APC—malignant glioma	0.000281	0.000492	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CASP3—malignant glioma	0.00028	0.000491	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL2—malignant glioma	0.00028	0.00049	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—BRAF—malignant glioma	0.000279	0.00049	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EGF—malignant glioma	0.000277	0.000486	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTPN11—malignant glioma	0.000276	0.000483	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—BRAF—malignant glioma	0.000273	0.000479	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AKT2—malignant glioma	0.000272	0.000477	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—EGFR—malignant glioma	0.000271	0.000474	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AKT2—malignant glioma	0.000266	0.000466	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTEN—malignant glioma	0.000265	0.000465	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—EGFR—malignant glioma	0.000265	0.000464	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MMP9—malignant glioma	0.000265	0.000464	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—BRAF—malignant glioma	0.000264	0.000462	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PTEN—malignant glioma	0.000263	0.000461	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CD—malignant glioma	0.000261	0.000458	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—PIK3CA—malignant glioma	0.000259	0.000453	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CB—malignant glioma	0.000257	0.000451	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AKT2—malignant glioma	0.000257	0.00045	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—AKT1—malignant glioma	0.000257	0.00045	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—KRAS—malignant glioma	0.000256	0.000448	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CD—malignant glioma	0.000256	0.000448	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTGS2—malignant glioma	0.000255	0.000447	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PIK3CA—malignant glioma	0.000253	0.000444	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—KRAS—malignant glioma	0.00025	0.000439	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—FGF2—malignant glioma	0.00025	0.000438	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CD—malignant glioma	0.000247	0.000432	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FGF2—malignant glioma	0.000245	0.000429	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—VEGFA—malignant glioma	0.000238	0.000417	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—STAT3—malignant glioma	0.000237	0.000416	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FGF2—malignant glioma	0.000236	0.000414	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—STAT3—malignant glioma	0.000235	0.000412	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PIK3CA—malignant glioma	0.000235	0.000412	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MDM2—malignant glioma	0.000234	0.00041	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RAF1—malignant glioma	0.000233	0.000409	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ERBB2—malignant glioma	0.000231	0.000404	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PIK3CA—malignant glioma	0.00023	0.000403	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MDM2—malignant glioma	0.000229	0.000401	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RAF1—malignant glioma	0.000228	0.0004	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CB—malignant glioma	0.000228	0.000399	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ERBB2—malignant glioma	0.000226	0.000396	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CB—malignant glioma	0.000223	0.000391	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTEN—malignant glioma	0.000222	0.000389	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MDM2—malignant glioma	0.000221	0.000387	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MYC—malignant glioma	0.00022	0.000386	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RAF1—malignant glioma	0.00022	0.000386	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CXCL8—malignant glioma	0.000219	0.000383	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MYC—malignant glioma	0.000219	0.000383	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ERBB2—malignant glioma	0.000218	0.000382	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—EGFR—malignant glioma	0.000216	0.000378	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CB—malignant glioma	0.000215	0.000377	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CXCL8—malignant glioma	0.000214	0.000375	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EGFR—malignant glioma	0.000214	0.000375	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—AKT1—malignant glioma	0.000211	0.00037	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CASP3—malignant glioma	0.000209	0.000367	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL2—malignant glioma	0.000209	0.000366	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—AKT1—malignant glioma	0.000207	0.000363	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CXCL8—malignant glioma	0.000207	0.000362	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CASP3—malignant glioma	0.000205	0.000359	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL2—malignant glioma	0.000205	0.000359	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—KRAS—malignant glioma	0.000204	0.000357	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—KRAS—malignant glioma	0.000202	0.000354	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MMP9—malignant glioma	0.000198	0.000347	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CASP3—malignant glioma	0.000198	0.000347	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL2—malignant glioma	0.000197	0.000346	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PTEN—malignant glioma	0.000197	0.000345	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MMP9—malignant glioma	0.000194	0.00034	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PTEN—malignant glioma	0.000193	0.000338	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—AKT1—malignant glioma	0.000192	0.000336	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—AKT1—malignant glioma	0.000188	0.000329	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CA—malignant glioma	0.000187	0.000328	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MMP9—malignant glioma	0.000187	0.000328	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTEN—malignant glioma	0.000186	0.000326	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CA—malignant glioma	0.000186	0.000325	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TP53—malignant glioma	0.00018	0.000315	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—VEGFA—malignant glioma	0.000178	0.000311	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—STAT3—malignant glioma	0.000176	0.000308	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—VEGFA—malignant glioma	0.000174	0.000305	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—STAT3—malignant glioma	0.000172	0.000302	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—VEGFA—malignant glioma	0.000168	0.000294	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—STAT3—malignant glioma	0.000166	0.000291	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MYC—malignant glioma	0.000163	0.000287	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MYC—malignant glioma	0.00016	0.000281	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EGFR—malignant glioma	0.00016	0.00028	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CA—malignant glioma	0.000157	0.000275	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EGFR—malignant glioma	0.000157	0.000274	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MYC—malignant glioma	0.000154	0.000271	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—AKT1—malignant glioma	0.000153	0.000268	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AKT1—malignant glioma	0.000152	0.000266	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KRAS—malignant glioma	0.000151	0.000265	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EGFR—malignant glioma	0.000151	0.000265	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KRAS—malignant glioma	0.000148	0.000259	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KRAS—malignant glioma	0.000143	0.00025	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CA—malignant glioma	0.000139	0.000243	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CA—malignant glioma	0.000136	0.000238	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TP53—malignant glioma	0.000134	0.000235	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TP53—malignant glioma	0.000131	0.00023	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CA—malignant glioma	0.000131	0.00023	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—AKT1—malignant glioma	0.000128	0.000224	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TP53—malignant glioma	0.000127	0.000222	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AKT1—malignant glioma	0.000113	0.000199	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AKT1—malignant glioma	0.000111	0.000195	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AKT1—malignant glioma	0.000107	0.000188	CbGpPWpGaD
